Atai Life Sciences Wins $11.4 Million Grant From National Institutes of Health

MT Newswires Live09-18

ATAI Life Sciences (ATAI) said Thursday it was awarded a multi-year, milestone-driven grant worth up to $11.4 million by the National Institute on Drug Abuse, under the National Institutes of Health.

The grant will provide non-dilutive funding to advance Atai Life Sciences' 5-HT2A/2C receptor agonist program, which aims to develop novel compounds that will modulate serotonin receptors implicated in addiction, the company said.

Shares of the company were up nearly 3% in recent Thursday premarket activity.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法